Appareil pulmonaire
CheckMate 592 (CA209-592)
Protocol Title: An Exploratory Study of the Biologic Effects and Biomarkers of Nivolumab in combination with Ipilimumab in Subjects with Treatment-Naive Stage IV or recurrent Non-Small Cell Lung Cancer (NSCLC).
Paris
NICOLAS GIRARD